TDOC Teladoc Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TDOC

Price (delayed)

$8.89

Market cap

$1.62B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.86

Enterprise value

$1.8B

?
Relative Growth: Rel. Growth: 35
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 56
Relative Profitability: Rel. Profitability: 39

Teladoc Health is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst ...

Highlights
The company's EPS rose by 32% YoY and by 13% QoQ
TDOC's net income is up by 31% year-on-year and by 13% since the previous quarter
TDOC's quick ratio has dropped by 67% year-on-year but it is up by 6% since the previous quarter
Teladoc Health's equity has decreased by 7% YoY
Teladoc Health's gross profit has decreased by 4.1% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.teladochealth.com
Peers: HCA BKD CYH

Key stats

What are the main financial stats of TDOC

TDOC stock price

How has the Teladoc Health stock price performed over time
Intraday
3.01%
1 week
37.83%
1 month
61.05%
1 year
9.21%
YTD
27%
QTD
53.28%

Financial performance

How have Teladoc Health's revenue and profit performed over time
Revenue
$2.47B
Gross profit
$1.69B
Operating income
-$162.96M
Net income
-$154.82M
Gross margin
68.6%
Net margin
-6.3%
TDOC's operating income is up by 41% YoY and by 13% from the previous quarter
The operating margin has grown by 39% YoY and by 12% from the previous quarter
TDOC's net income is up by 31% year-on-year and by 13% since the previous quarter
TDOC's net margin is up by 28% YoY and by 11% from the previous quarter

Price vs fundamentals

How does TDOC's price correlate with its fundamentals

Growth

What is Teladoc Health's growth rate over time

Valuation

What is Teladoc Health stock price valuation
P/E
N/A
P/B
1.25
P/S
0.66
EV/EBIT
N/A
EV/EBITDA
7.5
EV/Sales
0.73
The company's EPS rose by 32% YoY and by 13% QoQ
The stock's price to book (P/B) is 39% more than its last 4 quarters average of 0.9 and 14% more than its 5-year quarterly average of 1.1
Teladoc Health's equity has decreased by 7% YoY
The P/S is 56% below the 5-year quarterly average of 1.5 but 32% above the last 4 quarters average of 0.5
TDOC's revenue is down by 2.4% year-on-year

Efficiency

How efficient is Teladoc Health business performance
The company's return on sales rose by 38% YoY and by 14% QoQ
Teladoc Health's ROE has increased by 26% YoY and by 11% from the previous quarter
TDOC's return on assets is up by 21% year-on-year and by 13% since the previous quarter
Teladoc Health's return on invested capital has decreased by 19% QoQ and by 9% YoY

Dividends

What is TDOC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TDOC.

Financial health

How did Teladoc Health financials performed over time
Teladoc Health's total assets is 87% higher than its total liabilities
The current ratio has dropped by 68% year-on-year but it is up by 4.8% since the previous quarter
TDOC's quick ratio has dropped by 67% year-on-year but it is up by 6% since the previous quarter
TDOC's debt is 21% less than its equity
Teladoc Health's equity has decreased by 7% YoY
The debt to equity has grown by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.